Search Results - D. O. Shatalov
- Showing 1 - 9 results of 9
-
1
-
2
-
3
Development and validation of the method of control monomer impurities guanidine hydrochloride in pharmaceutical substance “branched hydrochloride oligo(hexamethyleneguanidine)”... by S. A. Kedik, D. O. Shatalov, S. G. Beksaev, I. P. Sedishev, E. S. Zhavoronok, V. V. Suslov, A. V. Panov
Published 2014-04-01
Article -
4
-
5
OPTIMIZATION OF THE RHEOLOGICAL PARAMETERS OF PILOT LIQUID DOSAGE FORMS IN THE DEVELOPMENT OF SPRAY PREPARATION AND TECHNOLOGY FOR ORAL CAVITY DISEASES TREATMENT by P. G. Mizina, S. M. Levachev, P. M. Masese, A. V. Panov, A. E. Harlov, N. V. Sugak, D. O. Shatalov
Published 2019-01-01
Article -
6
Implementation of pharmaceutical development using multivariate analysis of multi-criteria optimization on the example of the stage of purification of oligohexamethyleneguanidine h... by D. O. Shatalov, K. N. Trachuk, A. V. Aydakova, D. A. Akhmedova, I. S. Ivanov, D. S. Minenkov, I. Yu. Blazhevich, S. A. Kedik
Published 2023-08-01
Article -
7
Study of the Effect of the Pharmaceutical Substance Branched Oligohexamethylene Guanidine Hydrosuccinate in Relation to Microorganisms by I. S. Ivanov, D. O. Shatalov, S. A. Kedik, I. P. Sedishev, N. E. Grammatikova, A. V. Aydakova, K. N. Trachuk, E. I. Yazykova
Published 2020-05-01
Article -
8
-
9
Quantitation of polysorbate 80 in recombinant protein formulation using high-performance liquid chromatography by A. D. Askretkov, D. O. Shatalov, N. V. Orlova, D. I. Zybin, V. V. Nikolaeva, A. A. Klishin, E. S. Tuzova, D. S. Minenkov, S. A. Kedik, Yu. A. Seregin
Published 2022-04-01
Article